|
Novartis Animal Health US, Inc.
3200 Northline Avenue
Suite 300 
Greensboro, NC 27408 MEDIA RELEASE Contact: Joseph Burkett
336-387-1006
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Novartis gives $225,000 grant to Oklahoma State University National Center for Veterinary ParasitologyGreensboro, N.C., Oct., 2008 — Novartis Animal Health today announced a donation of $225,000 to the Oklahoma State University Foundation to become the first industry partner of National Center for Veterinary Parasitology (NCVP).
This partnership will help accomplish the mission of the NCVP by expanding the many developments made in controlling parasitic diseases of animals through integrated programs of applied graduate and residency training, targeted research initiatives, and a diagnostic and consulting service that serves the veterinary profession worldwide.
“Novartis shares the Oklahoma State University vision for the Center and will be an active sponsor in support of its mission,” said Fabian Kausche, global head of research and development at Novartis Animal Health who holds a Master of Science and a doctorate of veterinary medicine. “We look forward to improving the way we serve the veterinary profession through our involvement in the NCVP.”
The OSU NCVP will be a national resource for diagnostic testing and will help fill a great need for clinically oriented veterinary parasitologists who can meet current and future demands of the industry.
“In the last several years there has been a decline of veterinary parasitology training in the U.S.,” said Dr. Michael Lorenz, dean of the Center for Veterinary Health Sciences. “The NCVP is an opportunity for us to continue training in the discipline of veterinary parasitology and to provide a source for national diagnostic testing.”
As a founding partner, Novartis will offer the program financial support, help guide and develop the NCVP as a member of its advisory board and interact with graduate students and residents in training. The $225,000 commitment by Novartis will help make the center operational by providing support for laboratory renovations and related start-up costs. Renovations for the center are scheduled to begin in 2009 with graduate studies starting in 2010.
About Novartis Animal Health Novartis Animal Health researches, develops and commercializes leading animal treatments that meet the needs of pet owners, farmers and veterinarians. Headquartered in Basel, Switzerland, Novartis Animal Health conducts business in 40 countries and employees about 2,700 people worldwide. For more information, please consult http://www.ah.novartis.com/. About Novartis Novartis AG provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group’s continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 97,000 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com. |
Press Releases 
